Cargando…

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review

Hospital-acquired pneumonia, including ventilator-associated pneumonia (VAP) due to difficult-to-treat-resistant (DTR) Gram-negative bacteria, contributes significantly to morbidity and mortality in ICUs. In the era of COVID-19, the incidences of secondary nosocomial pneumonia and the demand for inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karaiskos, Ilias, Gkoufa, Aikaterini, Polyzou, Elena, Schinas, Georgios, Athanassa, Zoe, Akinosoglou, Karolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304325/ https://www.ncbi.nlm.nih.gov/pubmed/37374959 http://dx.doi.org/10.3390/microorganisms11061459

Ejemplares similares

Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis
por: Tsiakalos, Aristotelis, et al.
Publicado: (2023)

Immune-mediated liver injury following COVID-19 vaccination
por: Schinas, Georgios, et al.
Publicado: (2023)

Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual
por: Schinas, Georgios, et al.
Publicado: (2023)

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
por: Giamarellou, Helen, et al.
Publicado: (2022)

Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment
por: Schinas, Georgios, et al.
Publicado: (2023)

COVID-19 Vaccination in Patients with Chronic Liver Disease
por: Schinas, Georgios, et al.
Publicado: (2022)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016)

COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Understanding and Implementing Diagnostic Stewardship: A Guide for Resident Physicians in the Era of Antimicrobial Resistance
por: Schinas, Georgios, et al.
Publicado: (2023)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)

Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation
por: Gotoda, Mai, et al.
Publicado: (2022)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

Effectiveness of treatment with nebulized colistin in patients with COPD
por: Bruguera-Avila, Nuria, et al.
Publicado: (2017)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
por: Feng, Xiaoxuan, et al.
Publicado: (2021)

The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria
por: Zhou, Huijing, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
por: Fan, Yaxin, et al.
Publicado: (2022)

Naringenin restores colistin activation against colistin-resistant gram-negative bacteria in vitro and in vivo
por: Xu, Mengxin, et al.
Publicado: (2022)

Flufenamic Acid, a Promising Agent for the Sensitization of Colistin-Resistant Gram-Negative Bacteria to Colistin
por: Zhang, Yi, et al.
Publicado: (2023)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

The impact of age on intensive care
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria in Vitro and in Vivo
por: Zhang, Ying, et al.
Publicado: (2021)

Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins
por: Hashemi, Marjan M., et al.
Publicado: (2017)

Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance
por: Stokes, Jonathan M., et al.
Publicado: (2017)

Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria
por: Gadar, Kavita, et al.
Publicado: (2023)

Colistin-induced Acquired Bartter-like Syndrome: A Rare Cause of Difficult Weaning
por: Mahendran, AJ, et al.
Publicado: (2020)

Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
por: Pourheidar, Elham, et al.
Publicado: (2019)

Methanesulfonate (MSA) Catabolic Genes from Marine and Estuarine Bacteria
por: Henriques, Ana C., et al.
Publicado: (2015)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Using Colistin as a Trojan Horse: Inactivation of Gram-Negative Bacteria with Chlorophyllin
por: Richter, Peter, et al.
Publicado: (2019)

Thymol Increases Sensitivity of Clinical Col-R Gram-Negative Bacteria to Colistin
por: Yao, Zhuocheng, et al.
Publicado: (2022)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

Synergistic Activity and Biofilm Formation Effect of Colistin Combined with PFK-158 Against Colistin-Resistant Gram-Negative Bacteria
por: Chen, Liqiong, et al.
Publicado: (2021)

Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria
por: Gogry, Firdoos Ahmad, et al.
Publicado: (2021)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kh7skhkuhculqne6pbqb92k78c